| Literature DB >> 23295999 |
Abstract
India has become a hotbed of clinical trials, but recent reports of safety lapses have prompted calls for better regulation in this area. Currently, trial requirements can be relaxed if doing so is in the 'public interest', but a clearer definition of what this means is needed before this provision should be used.Mesh：
Year: 2013 PMID： 23295999 DOI： 10.1038/nm0113-15
Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440